http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4038389-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9414eb8baa5e3ff1d70c9b21b4cdb1ba |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-487 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-35 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5695 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate | 2020-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c725c634f4648f8a36c5348ff66699f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0356eedca4a9ed0c0efccd371a285d5 |
publicationDate | 2022-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-4038389-A1 |
titleOfInvention | Method for diagnosing tuberculosis in urine samples |
abstract | The invention provides a method for diagnosing and treating tuberculosis (TB). The method comprises testing a urine sample from a subject suspected of having TB for the presence of at least two human-derived biomarkers, of which one is SAA1 and the other is RETN or RBP4. The urine sample can also be tested for the presence of one or more additional biomarkers selected from LILRB4, IL18BP, SERPINA3, CD59, IGLV3.21, IGKV1.17, SAA2, CRP, TSP4, AXA81, A8MUE1, 053764_MYCTU (Rv0567), I6Y0W5_MYCTU (fadE19, Rv2500c), Q79FP1 _MYCTU (PE_PGRS28, Rv1452c), HTPG_MYCTU (htpG, Rv2299c), RPOB_MYCTU (rpoB, Rv0667), EFTU_MYCTU (tuf, Rv0685), ACR_MYCTU (hspX, Rv2031c), CH602_MYCTU (groEL2, Rv0440), CLPP1_MYCTU (clpP1, Rv2461c) and/or CH10_MYCTU (10kDa chaperonin, Rv3418c). |
priorityDate | 2019-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.